Similar Items: Comparing the influence of regularly prescribed pharmaceuticals on the chemotactic effects of autologous blood clots in the context of diabetic wounds
- Immune cell dysfunction and eicosanoid imbalance in chronic diabetic wounds
- Record review of the management of patients admitted for diabetic foot complications
- A retrospective review of diabetic foot ulcers treated with hyperbaric oxygen therapy in the Kingdom of Bahrain
- Blood coagulopathy and dysregulated circulating proteins associated with type 2 diabetes mellitus
- Tailoring the model of creative ability to patients with diabetic foot problems
- A macrophage-based cell therapy approach for the treatment of non-healing diabetic wounds
Author: Van de Vyver, Mari
- The therapeutic efficacy of ascorbic acid 2 phosphate, n-acetylcysteine and metformin against diabetes mellitus associated cellular senescence.
- miRNA signature of healthy vs impaired mesenchymal stem cells as a biomarker for autologous stem cell therapy
- Using STORM and TIRF in tandem to investigate adherence and migration patterns in stem cells
- N-acetylcysteine and ascorbic acid-2-phosphate incorporatedhydrogels as autologous stem cell delivery system for the treatment of diabetic wounds.
- Stem cell impairment associated with type 2 diabetes mellitus : investigating the effects of obesity-associated inflammation on mesenchymal stem cell function
- A comparison of the wound healing dynamics in an acute and newly developed chronic wound model using Neutral endopeptidase, an inhibitor of Substance P.